Sponsors & Exhibitors

Lead

Burjeel Medical City in MBZ City, Abu Dhabi, is a 400-bed quaternary care hospital. The 1.2 million-square-foot hospital offers 24-hour Paediatric and Adult emergency care, Paediatric Extra-Corporeal Membrane Oxygenation (ECMO) as well as comprehensive cancer care that includes medical, surgical, and radiation oncology specialities to treat a range of cancers including paediatric cancers. It does so while offering advanced clinical services across other diverse specialities and subspecialties. It also houses the UAE's largest long-term care and rehabilitation centre, as well as the Middle East's first-of-its-kind laboratory, powered by Roche's Total Lab Automation & Infinity Lab system, capable of executing over 10 million tests each year. It's a world-class facility equipped with cutting-edge medical technologies including iMRI, VershHD, PET-CT, SPECT/CT 1.5T, 3T MRI, 256 slice and 128 slice CT, and the Hologic Dexa Scan, among other technologies.

Platinum

Emmaus Life Sciences, Inc. is a biopharmaceutical company engaged in the discovery, development and commercialization of innovative treatments and therapies primarily for rare and orphan diseases. Our initial efforts have focused on treatments for Sickle Cell Disease, a genetic disorder. Emmaus's lead commercial product is Endari®, an oral pharmaceutical grade L-glutamine treatment indicated to reduce acute complications of sickle cell disease in adult and pediatric patients five years of age and older.

Gold

CSL Behring's portfolio of innovative medicines includes a wide range of recombinant and plasma-derived products for treating bleeding disorders, immune deficiencies and chronic inflammatory demyelinating polyneuropathy, as well as hereditary angioedema and Alpha 1 Antitrypsin Deficiency.

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular & Metabolic Diseases and Respiratory. The Company also is selectively active in the areas of autoimmunity, neuroscience and infection. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.

The University of Chicago Medicine, or UChicago Medicine, is one of America’s leading academic medical institutions. Today, UChicago Medicine operates four inpatient hospitals and 10 ambulatory facilities around the Chicago area, including downtown Chicago, the city’s south suburbs, and northwest Indiana. Developing projects include plans to build a new $633 million, 500,000-square-foot freestanding cancer center and additional outpatient centers. UChicago Medicine’s physicians and researchers have helped shape modern medicine. They’re proven pioneers in organ transplantation, the genetics of cancer, chemotherapy, and life-changing digestive disease treatments among many other breakthroughs. The 12 Noble Prize laureates affiliated with UChicago Medicine are fruition of our long tradition of groundbreaking medical research.

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders.

Children's Hospital of Philadelphia (CHOP) is the nation's first hospital devoted exclusively to the care of children. Since our start in 1855, CHOP has been the birthplace for countless breakthroughs and dramatic firsts in pediatric medicine. Built on a foundation of delivering safe, high-quality, family-centered care, the Hospital has fostered medical discoveries and innovations that have improved pediatric healthcare and saved countless children’s lives. Today, families facing complex conditions come to CHOP from all over the world, and our compassionate care and innovation has repeatedly earned us a top spot on the U.S. News & World Report's Honor Roll of the nation's best children's hospitals.

Children’s National Hospital is a leading pediatric health system located in the heart of Washington, DC. Serving children since 1870, Children’s National houses over 600 Pediatric physician experts across 60 specialties, and it is home to the Sheikh Zayed Campus for Advanced Children’s Medicine. Proudly named #1 in Neonatology for the fourth consecutive year and one of the top 10 pediatric hospitals nationally by U.S. News & World Report 2020-21, in addition to 7 specialties ranked in the top 10 for the tenth straight year. Thousands of patients are welcomed every year to the Global Services Division, treating children across 20 countries around the world with in-country liaisons in Kuwait and the United Arab Emirates.

Silver

Sobi is an international biopharmaceutical company focused on rare diseases. We are dedicated to providing access to innovative treatments that transform life for people with rare diseases. We focus on two therapeutic areas – Haematology and Immunology – and also have a portfolio of Specialty Care products. Within Haematology, we have become a leading company in haemophilia, where we seek to shape new standards, optimise treatment, build evidence, create sustainable access and provide community support in haemophilia care.

SERB is a growing pharmaceutical company and a dedicated ally to healthcare providers treating patients with critical conditions, focusing on emergency care and rare diseases. For over 30 years we have made treating these complex and life-threatening conditions possible; supporting clinicians, healthcare systems and governments while offering hope to patients and their families. As a fully integrated company, we have the experience and capabilities to acquire, develop, and manufacture our medicines to the highest standards, and make them available worldwide through our secure supply chain. SERB operates in the US as BTG Pharmaceuticals.